Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Strong
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Strong
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.11 - 0.87
Trade Value (12mth)
AU$72,439.00
1 week
2.21%
1 month
-9.74%
YTD
202.17%
1 year
414.81%
All time high
0.87
EPS 3 yr Growth
-70.30%
EBITDA Margin
-12.90%
Operating Cashflow
$0m
Free Cash Flow Return
-4.30%
ROIC
-44.10%
Interest Coverage
-10.10
Quick Ratio
1.10
Shares on Issue (Fully Dilluted)
215m
HALO Sector
Healthcare
Next Company Report Date
29-Jul-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
11 October 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
11 October 24 |
Letter to Shareholders with Respect to Notice of Meeting
×
Letter to Shareholders with Respect to Notice of Meeting |
01 October 24 |
Record quarterly sales revenue for Q1
×
Record quarterly sales revenue for Q1 |
30 September 24 |
Vision 27 Strategic Plan Presentation
×
Vision 27 Strategic Plan Presentation |
30 September 24 |
Vision 27 Video Presentation
×
Vision 27 Video Presentation |
25 September 24 |
Annual Report
×
Annual Report |
25 September 24 |
Appendix 4G & Corporate Governance Statement
×
Appendix 4G & Corporate Governance Statement |
19 September 24 |
Biome Commences Test Market In Canada
×
Biome Commences Test Market In Canada |
17 September 24 |
Date of AGM and Closing Date for Director Nominations
×
Date of AGM and Closing Date for Director Nominations |
10 September 24 |
Application for quotation of securities - BIO
×
Application for quotation of securities - BIO |
10 September 24 |
Secondary Trading Notice
×
Secondary Trading Notice |
04 September 24 |
FY24 Overview Investor Webinar Recording
×
FY24 Overview Investor Webinar Recording |
03 September 24 |
Q1 FY25 Revenue Guidance
×
Q1 FY25 Revenue Guidance |
26 August 24 |
Preliminary Final Report
×
Preliminary Final Report |
26 August 24 |
Financial Year 2024 Key Results
×
Financial Year 2024 Key Results |
26 August 24 |
Amended Preliminary Financial Report
×
Amended Preliminary Financial Report |
26 August 24 |
Investor Webinar
×
Investor Webinar |
26 August 24 |
Company Presentation
×
Company Presentation |
19 August 24 |
Clinically Proven Cholesterol Reducing Probiotic Launched
×
Clinically Proven Cholesterol Reducing Probiotic Launched |
29 July 24 |
Biome shares three-year revenue target
×
Biome shares three-year revenue target |
15 July 24 |
Quarterly Activities & Cashflow Report
×
Quarterly Activities & Cashflow Report |
05 July 24 |
Application for quotation of securities - BIO
×
Application for quotation of securities - BIO |
05 July 24 |
Secondary Trading Notice
×
Secondary Trading Notice |
01 July 24 |
Biome Achieves Record Sales Revenue in FY24
×
Biome Achieves Record Sales Revenue in FY24 |
21 June 24 |
Application for quotation of securities - BIO
×
Application for quotation of securities - BIO |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.